1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with nitroglycerin in 5 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (nitroglycerin) | Trials (nitroglycerin) | Recent Studies (post-2010) (nitroglycerin) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 12,659 | 2,240 | 1,398 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsueh, W; Zhang, C | 1 |
| Driscoll, EM; Jackson, CV; Kunkel, SL; Lucchesi, BR; Schumacher, WA | 1 |
| Kubota, S; Mafune, N; Miyatake, T; Miyazaki, K; Murashita, T; Watanabe, S; Yasuda, K | 1 |
| Caty, MG; Fung, HL; Khanna, A; Rossman, J | 1 |
| Bang, UC; Bendtsen, F; Nojgaard, C; Semb, S | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nitroglycerin
| Article | Year |
|---|---|
Pharmacological approach to acute pancreatitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Evidence-Based Medicine; Gabexate; Humans; Interleukin-10; Nitroglycerin; Octreotide; Pancreatitis; Platelet Activating Factor; Probiotics; Serine Proteinase Inhibitors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2008 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nitroglycerin
| Article | Year |
|---|---|
PAF-induced bowel necrosis. Effects of vasodilators.
Topics: Alprostadil; Animals; Hydralazine; Hypotension; Indazoles; Intestinal Diseases; Leukopenia; Male; Mesenteric Arteries; Necrosis; Nitroglycerin; Phenoxybenzamine; Platelet Activating Factor; Prazosin; Rats; Rats, Inbred Strains; SRS-A; Vasodilator Agents | 1991 |
Platelet-activating factor and the release of a platelet-derived coronary artery vasodilator substance in the canine.
Topics: Animals; Aspirin; Coronary Circulation; Coronary Vessels; Diphenhydramine; Dogs; Histamine H1 Antagonists; Male; Methacholine Compounds; Methysergide; Nitroglycerin; Platelet Activating Factor; Thrombocytopenia; Vasodilation | 1986 |
Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin.
Topics: Animals; Electric Stimulation; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Graft Rejection; Guinea Pigs; Heart Transplantation; In Vitro Techniques; Isoquinolines; Nitroglycerin; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Tetrahydroisoquinolines; Thromboxane A2; Transplantation, Heterologous; Ventricular Function, Left | 2000 |
Beneficial effects of intraluminal nitroglycerin in intestinal ischemia-reperfusion injury in rats.
Topics: Administration, Topical; Animals; Bile; Hemodynamics; Intestinal Diseases; Intestinal Mucosa; Intestines; Male; Models, Animal; Neutrophil Activation; Neutrophil Infiltration; Nitric Oxide; Nitroglycerin; Permeability; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Vasodilator Agents | 2003 |